Our lab recently identified the widely clinically used anti-depressant sertraline as a potent SHMT inhibitor that selectively inhibits proliferation of serine synthesis addicted breast cancer and RPL10 R98S T-ALL cells [5]. The gene discussed is SHMT1; the disease is breast cancer.